Chalazion
Conditions
Keywords
Chalazion, IPL, Meibomian gland function
Brief summary
The purpose of the present study was to investigate the efficacy of intense pulse light and meibomian glands expression in cases of recurrent chalazion after surgery.
Detailed description
We hypothesized that IPL application on the skin adjacent to eyelids after chalazion surgery will result in better meibomian gland function and lower recurrence. To date, it has not been previously reported the outcomes of the use of this technology for the management of chalazions recurrence. The purpose of the present study was to investigate the efficacy of intense pulse light and meibomian glands expression in cases of recurrent chalazion after surgery.
Interventions
DEVICEIPL-MGX
One week after lesion incision, the E-Eye machine (E-SWIN company, France) IPL treatment was administered to the skin area below the lower eyelid.13 Before treatment, the eyes were protected with opaque goggles and ultrasound gel was applied on the patient's face from tragus to tragus including the nose to conduct the light.
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
24 Years to 74 Years
Healthy volunteers
No
Inclusion criteria
* All patients had chronic unilateral recurrent chalazia that failed to resolve after conservative treatment that included warm compresses and antibiotic and steroid ophthalmic ointments.
Exclusion criteria
* (1) any intraocular inflammation, ocular infection, allergy, ocular surgery, or ocular trauma in the past 6 months; (2) any eyelid diseases or structural abnormality; (3) any systematic diseases may lead to dry eye or MGD; (4) skin cancer or pigmented lesion in the treatment zone.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recurrence rate of chalazia | an average of 1 year | The recurrence rate of the recurrent chalazia |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| NITBUT | an average of 1 year | non-invasive tear film breakup time |
| meibomian expressibility and quality | an average of 1 year | The expressibility and quality score of the meibum |
| TMH | an average of 1 year | tear meniscus height |
Countries
China
Contacts
Primary Contactjin x ming
Backup Contactzhu y rui
Outcome results
None listed